Previous close | 3.5000 |
Open | 2.7800 |
Bid | 0.8500 |
Ask | 2.6000 |
Strike | 15.00 |
Expiry date | 2024-08-16 |
Day's range | 2.7800 - 3.6000 |
Contract range | N/A |
Volume | |
Open interest | 47 |
BEDFORD, Mass., June 18, 2024--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that, effective on June 17, 2024, the company granted stock options to purchase an aggregate of 10,400 shares of common stock to one new employee, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4).
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
BEDFORD, Mass., June 03, 2024--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will present at the following upcoming investor conferences: